Point/Counterpoint: Why TMB Should or Should Not Be Assessed in Patients with Advanced NSCLC

Understanding the Effects of Time to Surgery on Upstaging for Stage I Non-Small Cell Lung Cancer

Nuances of PET Interpretation in Thoracic Oncology: More Than Just Lung Cancer

The Vital and Evolving Role of Bronchoscopic Technologies in Lung Cancer Management

The Treatment of Patients with Oligometastatic Lung Cancer

EGFR TKIs: A Marathon or Sprint?

CAR-T Cells for Lung Cancer: Q&A with Dr. Charu Aggarwal

Circulating Tumor Cell–Derived Patient eXplants: A New Tool for SCLC Research

The IASLC Issues Liquid Biopsy Statement to Aid Understanding of Rapid Innovation

Global Insights on New Clinical Practice Guideline for the Treatment of Malignant Pleural Mesothelioma

HLA LOH As an Immune Evasive Mechanism in TRACERx NSCLC

NCCN Guidelines Updated for 2018: Keeping Pace with Data